Dinaciclib
Dinaciclib (SCH 727965) is a potent and selective inhibitor of CDK1, CDK2, CDK5, and CDK9 with antitumor activity. It has been investigated in vitro and in vivo for oncology research, particularly in studies of cell cycle arrest and transcription inhibition in various cancer models.
Product Specifications
CAS Number
779353-01-4
Product Name Alternative
Dinaciclib, Cyclin dependent kinase, CDK5, CDK9, CDK, CDK1, CDK2, Apoptosis, inhibit, Inhibitor, SCH727965, SCH-727965, SCH 727965, PS095760, PS-095760, PS 095760
Field of Research
Cell Biology
Purity
98.21% (May vary between batches)
Solubility
DMSO:130 mg/mL (327.88 mM) ; Ethanol:8 mg/mL (20.18 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (12.61 mM)
Smiles
N (CC1=CN (=O) =CC=C1) C=2N3C (N=C (C2) N4[C@H] (CCO) CCCC4) =C (CC) C=N3
Molecular Formula
C21H28N6O2
Molecular Weight
396.49
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15277040 1 Vial
Lentiviral mouse Ccdc63 shRNA (UAS) - Lentiviral mouseCcdc63 shRNA (UAS, GFP) (25)
Sign In for Pricing
View Details 042350-AP 200 µL
ST5, CT (ST5, DENND2B, HTS1, Suppression of tumorigenicity 5 protein, DENN domain-containing protein 2B, HeLa tumor suppression 1) (AP) discontinued
Sign In for Pricing
View Details